Investigation path
FIND
AbbVie Inc
ABBV
RESOLVE
Backed Assets · Ondo Assets
2 issuers
TRACE
3 tokenized representations
ABBVX · ABBVon · WABBVX
UnderScope Lens
Representation check
A compact comparison of AbbVie Inc across the reported market reference, tokenized aggregate, and issuer wrappers.
Market reference
—
No priced CMC venue reference
Tokenized aggregate
$270.93
Aggregate wrapper price
Wrapper dispersion
+0.02%
2 priced wrappers · tight range
AbbVie Inc has 2 priced issuer wrappers spanning +0.02% from low to high. No priced CMC market reference was available for this check.
Underlier
AbbVie Inc[ABBV]
Stock · Pharmaceutical Preparations · New York Stock Exchange
Tokenized price
$270.93
Rank #26
- Primary exchange
- New York Stock Exchange
- Industry
- Pharmaceutical Preparations
- Founded
- 2012-04-09
- Employees
- 55,000
- CIK
- 0001551152
Tokenized market cap
$275.08K
24h tokenized volume
$230.2K
Tokenized exposure
3wrappers
Source
Average across issuer wrappers, not a cash last
Real-world asset
About the underlier
The instrument being tokenized — not the on-chain wrapper.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
- Rank
- 26
- Asset type
- Stock
- Primary exchange
- New York Stock Exchange
- Industry
- Pharmaceutical Preparations
- Founded
- 2012-04-09
- Employees
- 55,000
- SEC CIK